Jump to Content
Sign in
Sign up
HOME
BROWSE
ABOUT THE JOURNAL
Editorial Board
Journal Facts
Open Access Policy
Reprints/Permissions
Advertising
Contact Us
Privacy Policy
ISSUES
Current Issue
Previous Issues
Future Issues
Supplemental Issues
AHEAD OF PRINT
FOR AUTHORS
Submit a Manuscript
Author Instructions
Journal Policies
Transformative Journal Status
Author Fees
FOR SUBSCRIBERS
Members
Institutions
Cost
HELP
How to subscribe
Forgot Password
FAQ
COVID-19
ASTMH
Advanced Search
Help
ASTMH
Sign in
Sign up
HOME
BROWSE
ABOUT THE JOURNAL
Editorial Board
Journal Facts
Open Access Policy
Reprints/Permissions
Advertising
Contact Us
Privacy Policy
ISSUES
Current Issue
Previous Issues
Future Issues
Supplemental Issues
AHEAD OF PRINT
FOR AUTHORS
Submit a Manuscript
Author Instructions
Journal Policies
Transformative
Author Fees
FOR SUBSCRIBERS
Members
Institutions
Cost
HELP
How to subscribe
Forgot Password
FAQ
COVID-19
Search
Advanced Search
Help
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Previous Issue
Next Issue
Volume 69 (2003): Issue 6_suppl (Dec 2003): Live-attenuated dengue vaccine development
Publication Date:
01 Dec 2003
Get eTOC Alerts
Get Ahead of Print Alerts
Articles
PROGRESS IN DEVELOPMENT OF A LIVE-ATTENUATED, TETRAVALENT DENGUE VIRUS VACCINE BY THE UNITED STATES ARMY MEDICAL RESEARCH AND MATERIEL COMMAND
BIOLOGIC PROPERTIES OF DENGUE VIRUSES FOLLOWING SERIAL PASSAGE IN PRIMARY DOG KIDNEY CELLS: STUDIES AT THE UNIVERSITY OF HAWAII
MODIFICATION OF DENGUE VIRUS STRAINS BY PASSAGE IN PRIMARY DOG KIDNEY CELLS: PREPARATION OF CANDIDATE VACCINES AND IMMUNIZATION OF MONKEYS
PHASE 1 STUDIES OF WALTER REED ARMY INSTITUTE OF RESEARCH CANDIDATE ATTENUATED DENGUE VACCINES: SELECTION OF SAFE AND IMMUNOGENIC MONOVALENT VACCINES
VACCINATION OF HUMAN VOLUNTEERS WITH MONOVALENT AND TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE CANDIDATES
ATYPICAL ANTIBODY RESPONSES IN DENGUE VACCINE RECIPIENTS
SEROTYPE-SPECIFIC TH1 RESPONSES IN RECIPIENTS OF TWO DOSES OF CANDIDATE LIVE-ATTENUATED DENGUE VIRUS VACCINES
PHASE I TRIAL OF 16 FORMULATIONS OF A TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE
Save
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://www.ajtmh.org/abstract/journals/tpmd/69/6_suppl/tpmd.69.issue-6_suppl.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Share on facebook
Share on linkedin
Share on twitter
[18.97.9.173]
18.97.9.173
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
View Expanded
View Table
View Full Size
